ethinylestradiol indications/contra

Stem definitionDrug idCAS RN
estrogens 1082 57-63-6

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • ethinylestradiol betadex
  • ethynyl estradiol
  • ethinylestradiol
  • ethinyl estradiol
  • 17-ethinylestradiol
  • ethinyloestradiol
A semisynthetic alkylated ESTRADIOL with a 17-alpha-ethinyl substitution. It has high estrogenic potency when administered orally, and is often used as the estrogenic component in ORAL CONTRACEPTIVES.
  • Molecular weight: 296.41
  • Formula: C20H24O2
  • CLOGP: 3.68
  • LIPINSKI: 0
  • HAC: 2
  • HDO: 2
  • TPSA: 40.46
  • ALOGS: -4.64
  • ROTB: 0

Drug dosage:

DoseUnitRoute
25 mcg O
1.50 mg O

Approvals:

DateAgencyCompanyOrphan
June 25, 1943 FDA SCHERING

FDA Adverse Event Reporting System

scroll-->
MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Pulmonary embolism 6025.79 44.33 1448 6089 26440 3351882
Deep vein thrombosis 4131.33 44.33 1021 6516 20368 3357954
Unintended pregnancy 3638.97 44.33 661 6876 2462 3375860
Inappropriate schedule of drug administration 2969.23 44.33 721 6816 13032 3365290
Metrorrhagia 1894.97 44.33 373 7164 2271 3376051
Exposure during pregnancy 1749.17 44.33 554 6983 27009 3351313
Device expulsion 1574.99 44.33 453 7084 15740 3362582
Incorrect drug administration duration 1258.65 44.33 277 7260 3064 3375258
Product quality issue 1162.22 44.33 405 7132 26330 3351992
Menorrhagia 691.41 44.33 179 7358 4076 3374246
Thrombosis 528.44 44.33 192 7345 13898 3364424
Migraine 508.14 44.33 171 7366 9845 3368477
Pregnancy with contraceptive device 492.49 44.33 119 7418 2015 3376307
Cerebrovascular accident 454.91 44.33 225 7312 35063 3343259
Application site reaction 445.77 44.33 88 7449 533 3377789
Abortion spontaneous 438.09 44.33 156 7381 10629 3367693
Vaginal haemorrhage 431.79 44.33 134 7403 5933 3372389
Medical device discomfort 409.43 44.33 84 7453 634 3377688
Device breakage 397.65 44.33 112 7425 3520 3374802
Vaginal discharge 347.03 44.33 78 7459 943 3377379
Maternal exposure before pregnancy 342.95 44.33 78 7459 998 3377324
Pregnancy with contraceptive patch 341.78 44.33 49 7488 2 3378320
Product storage error 332.08 44.33 110 7427 6005 3372317
Headache 329.00 44.33 259 7278 91721 3286601
Intracranial venous sinus thrombosis 318.55 44.33 63 7474 385 3377937
Abnormal withdrawal bleeding 318.23 44.33 47 7490 13 3378309
Off label use 315.06 44.33 205 7332 53772 3324550
Abortion induced 302.85 44.33 91 7446 3600 3374722
Hypercoagulation 297.28 44.33 62 7475 511 3377811
Dysmenorrhoea 293.28 44.33 65 7472 733 3377589

Pharmacologic Action:

scroll-->
SourceCodeDescription
ATC G03CA01 GENITO URINARY SYSTEM AND SEX HORMONES
SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
ESTROGENS
Natural and semisynthetic estrogens, plain
ATC L02AA03 ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
ENDOCRINE THERAPY
HORMONES AND RELATED AGENTS
Estrogens
ATC G03AA01 GENITO URINARY SYSTEM AND SEX HORMONES
SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE
Progestogens and estrogens, fixed combinations
ATC G03AA02 GENITO URINARY SYSTEM AND SEX HORMONES
SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE
Progestogens and estrogens, fixed combinations
ATC G03AA03 GENITO URINARY SYSTEM AND SEX HORMONES
SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE
Progestogens and estrogens, fixed combinations
ATC G03AA04 GENITO URINARY SYSTEM AND SEX HORMONES
SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE
Progestogens and estrogens, fixed combinations
ATC G03AA05 GENITO URINARY SYSTEM AND SEX HORMONES
SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE
Progestogens and estrogens, fixed combinations
ATC G03AA06 GENITO URINARY SYSTEM AND SEX HORMONES
SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE
Progestogens and estrogens, fixed combinations
ATC G03AA07 GENITO URINARY SYSTEM AND SEX HORMONES
SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE
Progestogens and estrogens, fixed combinations
ATC G03AA08 GENITO URINARY SYSTEM AND SEX HORMONES
SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE
Progestogens and estrogens, fixed combinations
ATC G03AA09 GENITO URINARY SYSTEM AND SEX HORMONES
SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE
Progestogens and estrogens, fixed combinations
ATC G03AA10 GENITO URINARY SYSTEM AND SEX HORMONES
SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE
Progestogens and estrogens, fixed combinations
ATC G03AA11 GENITO URINARY SYSTEM AND SEX HORMONES
SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE
Progestogens and estrogens, fixed combinations
ATC G03AA12 GENITO URINARY SYSTEM AND SEX HORMONES
SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE
Progestogens and estrogens, fixed combinations
ATC G03AA13 GENITO URINARY SYSTEM AND SEX HORMONES
SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE
Progestogens and estrogens, fixed combinations
ATC G03AA15 GENITO URINARY SYSTEM AND SEX HORMONES
SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE
Progestogens and estrogens, fixed combinations
ATC G03AA16 GENITO URINARY SYSTEM AND SEX HORMONES
SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE
Progestogens and estrogens, fixed combinations
ATC G03AB01 GENITO URINARY SYSTEM AND SEX HORMONES
SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE
Progestogens and estrogens, sequential preparations
ATC G03AB02 GENITO URINARY SYSTEM AND SEX HORMONES
SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE
Progestogens and estrogens, sequential preparations
ATC G03AB03 GENITO URINARY SYSTEM AND SEX HORMONES
SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE
Progestogens and estrogens, sequential preparations
ATC G03AB04 GENITO URINARY SYSTEM AND SEX HORMONES
SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE
Progestogens and estrogens, sequential preparations
ATC G03AB05 GENITO URINARY SYSTEM AND SEX HORMONES
SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE
Progestogens and estrogens, sequential preparations
ATC G03AB06 GENITO URINARY SYSTEM AND SEX HORMONES
SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE
Progestogens and estrogens, sequential preparations
ATC G03AB07 GENITO URINARY SYSTEM AND SEX HORMONES
SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE
Progestogens and estrogens, sequential preparations
FDA EPC N0000175825 Estrogen
FDA MoA N0000000100 Estrogen Receptor Agonists
CHEBI has role CHEBI:76988 xenoestrogen
MeSH PA D004967 Estrogens
MeSH PA D006728 Hormones
MeSH PA D006730 Hormones, Hormone Substitutes, and Hormone Antagonists

Drug Use (View source of the data)

scroll-->
DiseaseRelationSNOMED_IDDOID
Premenstrual dysphoric disorder indication 596004
Contraception indication 13197004
Atrophic vaginitis indication 52441000 DOID:11968
Acne vulgaris indication 88616000
Postmenopausal osteoporosis indication 102447009
Menopausal flushing indication 198436008
Atrophic vulva indication 248861000 DOID:14275
Heart valve disorder contraindication 368009 DOID:4079
Hyperlipoproteinemia contraindication 3744001 DOID:1168
Hypocalcemia contraindication 5291005
Hypercholesterolemia contraindication 13644009
Hyperkalemia contraindication 14140009
Jaundice contraindication 18165001
Myocardial infarction contraindication 22298006 DOID:5844
Diplopia contraindication 24982008
Retinal hemorrhage contraindication 28998008
Depressive disorder contraindication 35489007 DOID:2848
Chloasma contraindication 36209000
Migraine contraindication 37796009 DOID:6364
Hypertensive disorder contraindication 38341003 DOID:10763
Disorder of gallbladder contraindication 39621005 DOID:0060262
Hypothyroidism contraindication 40930008 DOID:1459
Body fluid retention contraindication 43498006
Thrombosis of retinal vein contraindication 46085004 DOID:1727
Humoral hypercalcemia of malignancy contraindication 47709007
Chronic heart failure contraindication 48447003
Dementia contraindication 52448006
Hepatic porphyria contraindication 55056006 DOID:3133
Systemic lupus erythematosus contraindication 55464009 DOID:9074
Hyperlipidemia contraindication 55822004 DOID:1168
Benign mammary dysplasia contraindication 57993004
Acute nephropathy contraindication 58574008
Obstructive hyperbilirubinemia contraindication 59848001 DOID:13603
Thrombophlebitis contraindication 64156001 DOID:3875
Intermenstrual bleeding - irregular contraindication 64996003
Hypercalcemia contraindication 66931009 DOID:12678
Diabetes mellitus contraindication 73211009 DOID:9351
Hyperglycemia contraindication 80394007 DOID:4195
Heart failure contraindication 84114007 DOID:6000
Epilepsy contraindication 84757009 DOID:1826
Breast lump contraindication 89164003
Kidney disease contraindication 90708001 DOID:2527
Malignant neoplasm of liver contraindication 93870000 DOID:3571
Uterine leiomyoma contraindication 95315005 DOID:13223
Neoplasm of prostate contraindication 126906006 DOID:10283
Deep venous thrombosis contraindication 128053003
Seizure disorder contraindication 128613002 DOID:1826
Endometriosis contraindication 129103003 DOID:289
Bed-ridden contraindication 160685001
Liver function tests abnormal contraindication 166603001
Mammography abnormal contraindication 168750009
Angina pectoris contraindication 194828000
Asthma contraindication 195967001 DOID:2841
Cerebrovascular accident contraindication 230690007 DOID:6713
Pulmonary thromboembolism contraindication 233935004
Thrombophilia contraindication 234467004 DOID:2452
Disease of liver contraindication 235856003 DOID:409
Cholestasis of pregnancy contraindication 235888006
Endometrial carcinoma contraindication 254878006 DOID:2871
Benign prostatic hyperplasia contraindication 266569009 DOID:2883
Edema contraindication 267038008
Chorea contraindication 271700006
Pregnancy, function contraindication 289908002
Hypertriglyceridemia contraindication 302870006
Functional visual loss contraindication 313165001
Malignant tumor of cervix contraindication 363354003 DOID:4362
Malignant tumor of ovary contraindication 363443007 DOID:2394
Thromboembolic disorder contraindication 371039008
Adrenal cortical hypofunction contraindication 386584007 DOID:10493
Cardiovascular event risk contraindication 395112001
Breastfeeding (mother) contraindication 413712001
Disorder of coronary artery contraindication 414024009
Obesity contraindication 414916001 DOID:9970
Estrogen receptor positive tumor contraindication 416053008
Porphyria contraindication 418470004 DOID:13268
Optic disc edema contraindication 423341008 DOID:10175
Family history of malignant neoplasm of breast contraindication 429740004
Hypertensive urgency contraindication 443482000
Carcinoma of female breast contraindication 447782002
Smokes tobacco daily contraindication 449868002
Diabetes with Vascular Disease Complication contraindication
Major Surgery with Prolonged Post-Operative Immobilization contraindication
Nonspecific Abnormal Papanicolaou Smear of Cervix contraindication
Benign Hepatic Cell Adenoma contraindication
Breast Carcinoma in Males contraindication
Amenorrhea off-label use 14302001 DOID:13938
Female hypogonadism syndrome off-label use 16041008
Polycystic ovaries off-label use 69878008 DOID:11612
Dysmenorrhea off-label use 266599000
Postcoital contraception off-label use 268463003
Abnormal uterine bleeding unrelated to menstrual cycle off-label use 312984006
Menorrhagia off-label use 386692008

Acid dissociation constants calculated using MoKa v3.0.0

scroll-->
Dissociation levelDissociation constantType (acidic/basic)
pKa1 11.13 acidic

Orange Book patent data (new drug applications)

scroll-->
Formulation strengthTrade nameApplicantApplication numberApproval dateTypeDose formRoutePatent numberPatent expiration datePatent use
0.02MG LYBREL WYETH PHARMS INC N021864 May 22, 2007 DISCN TABLET ORAL 6500814 Sept. 3, 2018 PREVENTION OF PREGNANCY
0.035MG FEMCON FE APIL N021490 Nov. 14, 2003 RX TABLET, CHEWABLE ORAL 6667050 April 6, 2019 PREVENTION OF PREGNANCY
0.025MG NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE APIL N022573 Dec. 22, 2010 RX TABLET, CHEWABLE ORAL 6667050 April 6, 2019 PREVENTION OF PREGNANCY IN WOMEN WHO ELECT TO USE ORAL CONTRACEPTIVES AS A METHOD OF CONTRACEPTION
0.02MG MINASTRIN 24 FE APIL N203667 May 8, 2013 RX TABLET, CHEWABLE ORAL 6667050 April 6, 2019 PREVENTION OF PREGNANCY
0.01MG,0.01MG,N/A LO MINASTRIN FE APIL N204654 July 24, 2013 DISCN TABLET, CHEWABLE, TABLET ORAL 6667050 April 6, 2019 PREVENTION OF PREGNANCY
0.025MG,0.025MG,0.025MG ORTHO TRI-CYCLEN LO JANSSEN PHARMS N021241 Aug. 22, 2002 RX TABLET ORAL-28 6214815 June 9, 2019 CONTRACEPTION
0.05MG PREVEN EMERGENCY CONTRACEPTIVE KIT TEVA BRANDED PHARM N020946 Sept. 1, 1998 DISCN TABLET ORAL 6156742 Dec. 5, 2020 KIT ADAPTED AND DESIGNED TO PROVIDE BOTH DATA ON THE CURRENT REPRODUCTIVE STATUS OF A PATIENT AND CONTRACEPTION FOR THOSE WHO ARE NOT PREGNANT, BUT RECENTLY ENGAGED IN UNPROTECTED SEX
0.02MG YAZ BAYER HLTHCARE N021676 March 16, 2006 RX TABLET ORAL 7163931 Dec. 20, 2021 PREVENTION OF PREGNANCY
0.02MG,N/A BEYAZ BAYER HLTHCARE N022532 Sept. 24, 2010 RX TABLET ORAL 7163931 March 3, 2022 PREVENTION OF PREGNANCY
0.03MG,N/A SAFYRAL BAYER HLTHCARE N022574 Dec. 16, 2010 RX TABLET ORAL 7163931 March 3, 2022 PREVENTION OF PREGNANCY
0.03MG,0.01MG SEASONIQUE TEVA BRANDED PHARM N021840 May 25, 2006 RX TABLET ORAL 7615545 June 15, 2023 PREVENTION OF PREGNANCY
0.02MG,0.01MG LOSEASONIQUE TEVA BRANDED PHARM N022262 Oct. 24, 2008 RX TABLET ORAL 7615545 June 15, 2023 PREVENTION OF PREGNANCY
0.03MG,0.01MG SEASONIQUE TEVA BRANDED PHARM N021840 May 25, 2006 RX TABLET ORAL 7320969 Jan. 30, 2024 PREVENTION OF PREGNANCY IN WOMEN WHO ELECT TO USE ORAL CONTRACEPTIVES AS A METHOD OF CONTRACEPTION
None QUARTETTE TEVA BRANDED PHARM N204061 March 28, 2013 RX TABLET ORAL 8450299 Oct. 7, 2025 PREVENTION OF PREGNANCY
0.03MG,0.01MG SEASONIQUE TEVA BRANDED PHARM N021840 May 25, 2006 RX TABLET ORAL 7855190 Dec. 5, 2028 PREVENTION OF PREGNANCY
0.02MG,0.01MG LOSEASONIQUE TEVA BRANDED PHARM N022262 Oct. 24, 2008 RX TABLET ORAL 7855190 Dec. 5, 2028 PREVENTION OF PREGNANCY
0.01MG,0.01MG LO LOESTRIN FE APIL N022501 Oct. 21, 2010 RX TABLET ORAL 7704984 Feb. 2, 2029 LO LOESTRIN FE IS INDICATED FOR THE PREVENTION OF PREGNANCY IN WOMEN WHO ELECT TO USE ORAL CONTRACEPTIVES AS A METHOF OF CONTRACEPTION
0.01MG,0.01MG,N/A LO MINASTRIN FE APIL N204654 July 24, 2013 DISCN TABLET, CHEWABLE, TABLET ORAL 7704984 Feb. 2, 2029 PREVENTION OF PREGNANCY

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

scroll-->
TargetClassPharosUniProtActionTypeActivity value
(-log[M])
Mechanism
action
Bioact sourceMoA source
Estrogen receptor Nuclear hormone receptor AGONIST Kd 9.83 WOMBAT-PK CHEMBL
Mu-type opioid receptor GPCR Ki 4.96 DRUG MATRIX
Adenosine receptor A2a GPCR Ki 4.93 DRUG MATRIX
Sodium-dependent serotonin transporter Transporter Ki 7.54 DRUG MATRIX
Sodium-dependent noradrenaline transporter Transporter Ki 6.02 DRUG MATRIX
Glucocorticoid receptor Nuclear hormone receptor Ki 6.11 DRUG MATRIX
Sodium-dependent dopamine transporter Transporter Ki 6.35 DRUG MATRIX
Adenosine receptor A3 GPCR Ki 4.73 DRUG MATRIX
Kappa-type opioid receptor GPCR Ki 4.98 DRUG MATRIX
Sex hormone-binding globulin Secreted Kd 6.81 CHEMBL
Multidrug and toxin extrusion protein 2 Transporter IC50 4.69 CHEMBL
Multidrug and toxin extrusion protein 1 Transporter IC50 4.68 CHEMBL
Estrogen receptor beta Nuclear hormone receptor IC50 8.09 CHEMBL
Solute carrier family 22 member 2 Transporter IC50 5.66 CHEMBL
Androgen receptor Nuclear hormone receptor IC50 7.30 WOMBAT-PK
Aldehyde oxidase Enzyme IC50 6.24 WOMBAT-PK
5-hydroxytryptamine receptor 4 GPCR Ki 5.88 DRUG MATRIX
Arachidonate 15-lipoxygenase Enzyme IC50 5.25 DRUG MATRIX
Progesterone receptor Transcription factor Ki 6.86 DRUG MATRIX
Androgen receptor Transcription factor IC50 5.09 CHEMBL

External reference:

scroll-->
IDSource
4018022 VUID
N0000146366 NUI
C0015011 UMLSCUI
7071 IUPHAR_LIGAND_ID
D00554 KEGG_DRUG
423D2T571U UNII
437 INN_ID
DB00977 DRUGBANK_ID
CHEMBL691 ChEMBL_ID
5991 PUBCHEM_CID
4124 RXNORM
126097006 SNOMEDCT_US
4698 MMSL
d00229 MMSL
15432003 SNOMEDCT_US
4018022 VANDF
72166 MMSL
N0000007353 NDFRT
N0000146366 NDFRT
001286 NDDF
CHEBI:4903 CHEBI
D004997 MESH_DESCRIPTOR_UI
3WF PDB_CHEM_ID

Pharmaceutical products:

scroll-->
ProductCategoryIngredientsNDCFormQuantityRoute MarketingLabel
Taytulla HUMAN PRESCRIPTION DRUG LABEL 2 0023-5862 KIT 0.02 mg None NDA 19 sections
FEMCON Fe HUMAN PRESCRIPTION DRUG LABEL 2 0023-5970 KIT 0.04 mg None NDA 20 sections
GENERESS Fe HUMAN PRESCRIPTION DRUG LABEL 3 0023-6030 KIT 0.03 mg ORAL NDA 19 sections
Desogen HUMAN PRESCRIPTION DRUG LABEL 2 0052-0261 KIT 0.03 mg None NDA 15 sections
NuvaRing HUMAN PRESCRIPTION DRUG LABEL 2 0052-0273 INSERT, EXTENDED RELEASE 0.02 mg VAGINAL NDA 21 sections
Tri-Lo-Sprintec HUMAN PRESCRIPTION DRUG LABEL 6 0093-2140 KIT 0.03 mg None ANDA 18 sections
Tri-Lo-Sprintec HUMAN PRESCRIPTION DRUG LABEL 6 0093-2140 KIT 0.03 mg None ANDA 18 sections
Tri-Lo-Sprintec HUMAN PRESCRIPTION DRUG LABEL 6 0093-2140 KIT 0.03 mg None ANDA 18 sections
Jinteli HUMAN PRESCRIPTION DRUG LABEL 2 0093-3122 TABLET 5 ug ORAL ANDA 19 sections
Camrese HUMAN PRESCRIPTION DRUG LABEL 3 0093-3134 KIT 0.01 mg None NDA authorized generic 19 sections
Camrese HUMAN PRESCRIPTION DRUG LABEL 3 0093-3134 KIT 0.03 mg None NDA authorized generic 19 sections
Necon 1/35 HUMAN PRESCRIPTION DRUG LABEL 2 0093-3303 KIT 0.04 mg None ANDA 14 sections
Reclipsen HUMAN PRESCRIPTION DRUG LABEL 2 0093-3304 KIT 0.03 mg None ANDA 15 sections
Zenchent 0.4/35 HUMAN PRESCRIPTION DRUG LABEL 2 0093-3305 KIT 0.04 mg None ANDA 14 sections
Junel Fe HUMAN PRESCRIPTION DRUG LABEL 2 0093-5328 KIT 0.02 mg None ANDA 20 sections
Gianvi HUMAN PRESCRIPTION DRUG LABEL 2 0093-5423 KIT 0.02 mg None NDA authorized generic 20 sections
Rivelsa HUMAN PRESCRIPTION DRUG LABEL 7 0093-6031 KIT 0.03 mg None NDA authorized generic 19 sections
Rivelsa HUMAN PRESCRIPTION DRUG LABEL 7 0093-6031 KIT 0.02 mg None NDA authorized generic 19 sections
Rivelsa HUMAN PRESCRIPTION DRUG LABEL 7 0093-6031 KIT 0.03 mg None NDA authorized generic 19 sections
Rivelsa HUMAN PRESCRIPTION DRUG LABEL 7 0093-6031 KIT 0.01 mg None NDA authorized generic 19 sections
camrese Lo HUMAN PRESCRIPTION DRUG LABEL 3 0093-6148 KIT 0.01 mg None NDA authorized generic 19 sections
camrese Lo HUMAN PRESCRIPTION DRUG LABEL 3 0093-6148 KIT 0.02 mg None NDA authorized generic 19 sections
Kelnor 1/50 HUMAN PRESCRIPTION DRUG LABEL 2 0093-8073 KIT 50 ug None ANDA 15 sections
XULANE HUMAN PRESCRIPTION DRUG LABEL 2 0378-3340 PATCH 35 ug TRANSDERMAL ANDA 21 sections
LEVONORGESTREL AND ETHINYL ESTRADIOL HUMAN PRESCRIPTION DRUG LABEL 2 0378-6550 KIT 0.03 mg None ANDA 13 sections
NORGESTIMATE AND ETHINYL ESTRADIOL HUMAN PRESCRIPTION DRUG LABEL 6 0378-7277 KIT 0.03 mg None ANDA 17 sections
NORGESTIMATE AND ETHINYL ESTRADIOL HUMAN PRESCRIPTION DRUG LABEL 6 0378-7277 KIT 0.03 mg None ANDA 17 sections
NORGESTIMATE AND ETHINYL ESTRADIOL HUMAN PRESCRIPTION DRUG LABEL 6 0378-7277 KIT 0.03 mg None ANDA 17 sections
NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL HUMAN PRESCRIPTION DRUG LABEL 2 0378-7280 TABLET 0.02 mg ORAL ANDA 14 sections
LEVONORGESTREL AND ETHINYL ESTRADIOL HUMAN PRESCRIPTION DRUG LABEL 2 0378-7281 KIT 0.03 mg None ANDA 19 sections